首页> 外文期刊>Allergy >GA(2)LEN skin test study I: GA(2)LEN harmonization of skin prick testing: novel sensitization patterns for inhalant allergens in Europe.
【24h】

GA(2)LEN skin test study I: GA(2)LEN harmonization of skin prick testing: novel sensitization patterns for inhalant allergens in Europe.

机译:GA(2)LEN皮肤测试研究I:GA(2)LEN皮肤点刺测试的协调性:欧洲吸入性过敏原的新型致敏模式。

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND: Skin prick testing is the standard for diagnosing IgE-mediated allergies. However, different allergen extracts and different testing procedures have been applied by European allergy centres. Thus, it has been difficult to compare results from different centres or studies across Europe. It was, therefore, crucial to standardize and harmonize procedures in allergy diagnosis and treatment within Europe. AIMS: The Global Asthma and Allergy European Network (GA(2)LEN), with partners and collaborating centres across Europe, was in a unique position to take on this task. The current study is the first approach to implement a standardized procedure for skin prick testing in allergies against inhalant allergens with a standardized pan-European allergen panel. METHODS: The study population consisted of patients who were referred to one of the 17 participating centres in 14 European countries (n = 3034, median age = 33 years). Skin prick testing and evaluation was performed with the same 18 allergens in a standardized procedure across all centres. RESULTS: The study clearly shows that many allergens previously regarded as untypical for some regions in Europe have been underestimated. This could partly be related to changes in mobility of patients, vegetation or climate in Europe. CONCLUSION: The results of this large pan-European study demonstrate for the first time sensitization patterns for different inhalant allergens in patients across Europe. The standardized skin prick test with the standardized allergen battery should be recommended for clinical use and research. Further EU-wide monitoring of sensitization patterns is urgently needed.
机译:背景:皮肤点刺测试是诊断IgE介导的过敏的标准。但是,欧洲过敏中心采用了不同的过敏原提取物和不同的测试程序。因此,很难比较欧洲不同中心或研究的结果。因此,至关重要的是在欧洲范围内标准化和统一过敏诊断和治疗程序。目标:全球哮喘和过敏欧洲网络(GA(2)LEN)与欧洲各地的合作伙伴和合作中心处于承担这一任务的独特位置。当前的研究是采用标准化泛欧过敏原小组对吸入性过敏原过敏的皮肤点刺测试实施标准化程序的第一种方法。方法:研究人群包括在14个欧洲国家(n = 3034,中位年龄= 33岁)中被转诊到17个参与中心之一的患者。在所有中心以标准化程序对相同的18种过敏原进行皮肤点刺测试和评估。结果:该研究清楚地表明,许多以前被认为在欧洲某些地区不典型的过敏原被低估了。这可能部分与欧洲患者流动性,植被或气候变化有关。结论:这项大型的泛欧洲研究结果首次证明了欧洲患者不同吸入性过敏原的致敏模式。应推荐使用标准化过敏原电池进行标准化皮肤点刺试验,以用于临床使用和研究。迫切需要在欧盟范围内对敏化模式进行进一步监控。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号